BRD4 and metabolic dysfunction-associated steatohepatitis: Recent studies have increasingly implicated BRD4 in the regulation of non-alcoholic steatohepatitis, liver fibrosis, and inflammation [27, 28], thereby reinforcing its potential role in immune responses to S. japonicum infection.